Skip to content

A Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents

A Randomized Controlled Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01278563
Enrollment
280
Registered
2011-01-19
Start date
2011-01-31
Completion date
2013-06-30
Last updated
2011-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescence Obesity

Keywords

Low Glycemic Index Diet

Brief summary

Epidemiological studies suggest a role for a low glycemic index (GI) diet in the management of obesity and associated metabolic risks including diabetes. However, evidence from long-term, randomized controlled trials exploring the relationship between low GI diet, weight reduction and glycemia, particularly in children and adolescents, is lacking. Modern food-processing technology has produced many food products with high GI which may contribute to the burgeoning epidemic of obesity worldwide. Since dietary habits are shaped in early life, adolescence is a critical period to educate our young people to acquire a healthy eating habit to prevent obesity. The investigators hypothesized that, in Chinese adolescents, low GI diet results in greater reduction in body mass index and body fat percentage, enhanced insulin sensitivity and favorable changes of cardiometabolic risk factors compared to conventional diet after 12 months of intervention. This study is a randomized controlled trial of a low GI (\<55) versus conventional Chinese diet (GI\>/=70) in adolescents (12-month intervention followed by a 6-month observational period) to study; 1) the changes in body mass index and obesity associated changes in cardiometabolic profile; 2) the underlying hormonal factors associated with these changes.

Detailed description

This is a 12-month randomized controlled dietary interventional trial followed by a 6-month observational period. The objectives of this study include: 1. To study changes of body mass index, body fat percentage, insulin secretion, insulin resistance and obesity associated cardiometabolic factors; 2. To explore underlying neurohormonal mechanisms associated with these changes in both short- and long-term.

Interventions

dietitian interview and counselling for the low glycemic index diet group

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
15 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 15 and 18 years (inclusive) * Male or female of Chinese ethnicity * Body mass index \>/= 95th percentile of Hong Kong local age- and sex-specific reference * No major medical illness * Not on any chronic medications * Post-pubertal as ascertained by clinical assessment by endocrinologist * Willingness to give written informed consent by participants and his/her parents/guardian

Exclusion criteria

* Concurrent participation in any clinical trial, dietary intervention or weight loss program * Concomitant intake of weight reducing agent * Active and uncontrolled endocrine diseases including hypo- or hyperthyroidism, Cushing's syndrome, diabetes mellitus, etc. * Significant renal impairment, defined as serum creatinine \>150 umol/L and/or estimated glomerular filtration rate \<60ml/min/1.73m2 * Significant liver impairment, defined as \>2 times upper limit of alanine aminotransferase and asparate aminotransferase levels * Gastrointestinal problems that would prevent them from following the test diets * Active malignant disease * Pregnant or lactating * Any medical illness or condition including known non-compliance, as judged by the investigators as ineligible to participate the study

Design outcomes

Primary

MeasureTime frameDescription
body mass indexchange from baseline to 12 monthsbody mass index= body weight (kg) divided by square of body height (m2)

Secondary

MeasureTime frameDescription
other parameters of body compositionchange from baseline to 12 months1. waist circumference 2. body fat percentage

Countries

Hong Kong

Contacts

Primary ContactAlice PS Kong, FRCP
alicekong@cuhk.edu.hk+852 2632 2211
Backup ContactCherry KP Chiu, RN
cherrychiu@cuhk.edu.hk+852 2632 2211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026